To deliver any of the expanded scope services available, pharmacists and pharmacies must meet the requirements of and act in accordance with the relevant Class Authorities and Practice Standards for each condition (as detailed on this page).
Key requirements outlined in the Class Authorities, which are relevant for the delivery of all expanded scope services, include:
Specific eligibility criteria are in place to ensure patients receive safe and appropriate care.
For treatment of UTIs, patients must be:
If a patient does not meet the eligibility criteria to receive the service by a pharmacist, you must refer them to appropriate alternative care, such as their usual GP. Where GP referral or follow-up is required but the patient does not have a regular GP or that GP is unavailable (within an appropriate timeframe), contact healthdirect on 1800 022 222 for advice on patient disposition. *The term ‘female’ is used to include all people presumed female at birth.
To provide this service, pharmacists and pharmacies must meet the requirements of and operate in accordance with:
It is important that you read through these documents thoroughly to ensure compliance. Pharmacists carrying out uncomplicated UTI management consultations must do so in accordance with the flow chart of criteria and actions provided in the above Practice Standards.
Mandatory training for pharmacists to deliver this service includes:
Please refer to the Class Authority for additional training pathways accepted for Queensland-trained pharmacists.
In March 2025, the antibiotic Therapeutic Guidelines updated its recommendations for the management of uncomplicated UTIs prompting an update in the UTI Practice Standards.
This webinar, hosted by NSW Chief Health Officer, Dr Kerry Chant AO PSM, guides pharmacists through evidence-based management of UTIs, as well as regulatory requirements and best-practice documentation.
To receive hormonal contraception resupply services at a pharmacy, patients must:
The patient is eligible if they have run out of repeats or their prescription has expired, as long as they meet the above criteria.
If a patient does not meet the eligibility criteria to receive the service by a pharmacist, you must provide them with usual care, and refer them to their usual medical practitioner as appropriate.
*There are additional conditions for management of patients aged between 40 – 49 years (inclusive) due to the increased risk of comorbidities and other background risks. Refer to the Practice Standards for complete information.
It is important that you read through these documents thoroughly to ensure compliance. Pharmacists carrying out hormonal contraception resupply consultations must do so in accordance with the flow chart of criteria and actions provided in the above Practice Standards.
Management of minor skin conditions can only be offered to patients who present with:
*Patients must have been previously diagnosed with this condition by a medical practitioner.
It is important that you read through these documents thoroughly to ensure compliance. Pharmacists carrying out dermatology consultations must do so in accordance with the flow chart of criteria and actions provided in the above Practice Standards.
Pharmacies who provide expanded scope services are responsible for maintaining their own up-to-date service listings via healthdirect Service Finder. Please see directions for creating and maintaining your listing for more information.
Pharmacists are reminded that health practitioners who provide health services to children may be required to hold a Working with Children Check, and are mandatory reporters for suspected child abuse.
Please refer to the Office of the Children’s Guardian’s website for information relating to when a Working with Children Check is required, and the Department of Communities and Justice’s website for information relating to mandatory reporting.
Pharmacists can charge a consultation fee for patients seeking these services. This is at the discretion of the pharmacy.
This consultation fee will be in addition to the cost of any medicines supplied.
It is essential that you obtain financial consent from patients before commencing their consultation.
Pharmacists should reach out to their member organisations in the first instance for further advice and support regarding expanded scope service provision.
Information and updates on the NSW Pharmacy Trial, which tested safety and efficacy for community pharmacist delivery of these services, is available at NSW Pharmacy Trial .
For questions specifically relating to the research trial, please email the trial leads at NSWPharmacyTrial@newcastle.edu.au.
For general information, pharmacists should contact NSW Health at moh-pharmaceuticalservices@health.nsw.gov.au.
Pharmacies may promote the service offering using their own developed materials in accordance with relevant guidelines. Refer to Advertising health services | Therapeutic Goods Administration.
